AT
GSK icon

Arden Trust’s GSK GSK Stock Holding History

Arden Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,519
Closed -$167K – 500
2020
Q1 		$167K Sell
3,519
-851
-19% -$45.4K 0.03% 305
2019
Q4 		$257K Sell
4,370
-97
-2% -$5.4K 0.04% 293
2019
Q3 		$238K Sell
4,467
-383
-8% -$19.7K 0.04% 318
2019
Q2 		$242K Sell
4,850
-20
-0.4% -$1K 0.04% 305
2019
Q1 		$255K Buy
+4,870
New +$243K 0.04% 309
2018
Q4 		– Sell
-5,042
Closed -$253K – 339
2018
Q3 		$253K Buy
+5,042
New +$256K 0.04% 320
2018
Q2 		– Sell
-4,662
Closed -$228K – 362
2018
Q1 		$228K Sell
4,662
-49
-1% -$2.28K 0.04% 343
2017
Q4 		$209K Sell
4,711
-24
-0.5% -$1.11K 0.03% 338
2017
Q3 		$240K Buy
4,735
+465
+11% +$23.6K 0.04% 326
2017
Q2 		$230K Buy
4,270
+313
+8% +$16.7K 0.04% 336
2017
Q1 		$209K Sell
3,957
-678
-15% -$34.4K 0.03% 327
2016
Q4 		$224K Buy
4,635
+429
+10% +$21.2K 0.03% 317
2016
Q3 		$227K Sell
4,206
-41,407
-91% -$2.27M 0.03% 296
2016
Q2 		$2.47K Buy
45,613
+835
+2% +$44K 0.19% 124
2016
Q1 		$2.27M Sell
44,778
-1,512
-3% -$75.3K 0.18% 131
2015
Q4 		$2.33M Buy
46,290
+548
+1% +$27.9K 0.2% 121
2015
Q3 		$2.2M Buy
45,742
+4,680
+11% +$244K 0.18% 139
2015
Q2 		$2.14K Buy
41,062
+1,009
+3% +$56.8K 0.32% 81
2015
Q1 		$2.31K Buy
40,053
+18,648
+87% +$1.07M 0.34% 75
2014
Q4 		$1.14M Sell
21,405
-525
-2% -$29.4K 0.16% 128
2014
Q3 		$1.26M Buy
21,930
+3,369
+18% +$207K 0.17% 119
2014
Q2 		$1.24M Buy
18,561
+3,835
+26% +$260K 0.17% 118
2014
Q1 		$983K Sell
14,726
-148
-1% -$10K 0.12% 150
2013
Q4 		$993K Buy
14,874
+10,283
+224% +$667K 0.12% 141
2013
Q3 		$288K Sell
4,591
-954
-17% -$61.4K 0.04% 266
2013
Q2 		$346K Buy
+5,545
New +$352K 0.04% 250

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arden Trust's GSK Position: Q2 2020 in Review

Arden Trust sold out of GSK (GSK) in Q2 2020, closing a stake of 3,519 shares — an estimated $167K sold.

Arden Trust first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $2.33M in Q4 2015. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Arden Trust reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 3,519 GSK shares in Q2 2020, an estimated $167K.
  • Arden Trust first reported a position in GSK in Q2 2013 and held it in 26 quarters.
  • Arden Trust's GSK position peaked at $2.33M in Q4 2015.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.